Barings’s Alexion Pharmaceuticals ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-12,196
| Closed | -$1.4M | – | 657 |
|
|
2020
Q3 | $1.4M | Sell |
12,196
-2,472
| -17% | -$267K | 0.03% | 290 |
|
|
2020
Q2 | $1.32M | Hold |
14,668
| – | – | 0.04% | 250 |
|
|
2020
Q1 | $1.32M | Sell |
14,668
-2,042
| -12% | -$200K | 0.04% | 250 |
|
|
2019
Q4 | $1.79M | Buy |
16,710
+8,840
| +112% | +$945K | 0.05% | 257 |
|
|
2019
Q3 | $771K | Hold |
7,870
| – | – | 0.02% | 423 |
|
|
2019
Q2 | $1.03M | Buy |
7,870
+4,830
| +159% | +$623K | 0.02% | 376 |
|
|
2019
Q1 | $411K | Hold |
3,040
| – | – | 0.01% | 576 |
|
|
2018
Q4 | $296K | Sell |
3,040
-165
| -5% | -$19.5K | 0.01% | 598 |
|
|
2018
Q3 | $446K | Hold |
3,205
| – | – | 0.01% | 644 |
|
|
2018
Q2 | $397K | Buy |
3,205
+165
| +5% | +$19.3K | 0.01% | 696 |
|
|
2018
Q1 | $339K | Hold |
3,040
| – | – | 0.01% | 786 |
|
|
2017
Q4 | $364K | Sell |
3,040
-2,820
| -48% | -$343K | 0.01% | 793 |
|
|
2017
Q3 | $822K | Buy |
5,860
+2,820
| +93% | +$383K | 0.02% | 534 |
|
|
2017
Q2 | $370K | Buy |
+3,040
| New | +$354K | 0.01% | 696 |
|
|
2015
Q3 | – | Sell |
-2,840
| Closed | -$513K | – | 990 |
|
|
2015
Q2 | $513K | Sell |
2,840
-3,750
| -57% | -$647K | 0.02% | 686 |
|
|
2015
Q1 | $1.14M | Hold |
6,590
| – | – | 0.04% | 474 |
|
|
2014
Q4 | $1.22M | Buy |
6,590
+3,090
| +88% | +$573K | 0.05% | 419 |
|
|
2014
Q3 | $580K | Sell |
3,500
-6,440
| -65% | -$1.06M | 0.02% | 631 |
|
|
2014
Q2 | $1.55M | Buy |
9,940
+4,220
| +74% | +$666K | 0.06% | 384 |
|
|
2014
Q1 | $870K | Buy |
5,720
+3,060
| +115% | +$487K | 0.03% | 498 |
|
|
2013
Q4 | $354K | Hold |
2,660
| – | – | 0.01% | 705 |
|
|
2013
Q3 | $309K | Sell |
2,660
-1,170
| -31% | -$128K | 0.01% | 753 |
|
|
2013
Q2 | $353K | Buy |
+3,830
| New | +$369K | 0.02% | 691 |
|
Other funds holding ALXN
BBA
